NOV (NOV)
(Delayed Data from NYSE)
$11.96 USD
-0.27 (-2.21%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $11.96 0.00 (0.00%) 6:24 PM ET
5-Strong Sell of 5 5
A Value A Growth C Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, NOV Inc. has a market cap of $4.54B, which represents its share price of $12.23 multiplied by its outstanding shares number of 371.36M. As a mid-cap company, NOV's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
NOV 11.96 -0.27(-2.21%)
Will NOV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NOV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NOV
NOV Q2 Earnings Miss, Revenues Beat Estimates, Both Decrease Y/Y
Here's What Key Metrics Tell Us About Nov Inc. (NOV) Q2 Earnings
NOV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Nov Inc. (NOV) Q2 Earnings Miss Estimates
Oil States International (OIS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Factors You Need to Know Ahead of NOV's Q2 Earnings Release
Other News for NOV
Novo Nordisk downgraded to Neutral from Buy at UBS
RBC Capital Maintains Rating on NOV, Lowers Price Target | NOV Stock News
NOV Stock Rating Maintained, Price Target Lowered by Evercore ISI Group | NOV Stock News
JP Morgan Downgrades NOV, Lowers Price Target to $15.00 | NOV Stock News
NOV Price Target Reduced by Susquehanna Amid Diverse Global Opportunities